| PERIOD ENDING | 31-Dec-08 |
| Total Revenue | 138 |
| Cost of Revenue | 81 |
|
| Gross Profit | 58 |
|
| Operating Expenses |
| Research Development | 4 |
| Selling General and Administrative | 10 |
| Non Recurring |
-
|
| Others |
-
|
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss | 43 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | (1) |
| Earnings Before Interest And Taxes | 42 |
| Interest Expense | 0 |
| Income Before Tax | 42 |
| Income Tax Expense | (5) |
| Minority Interest |
-
|
| |
| Net Income From Continuing Ops | 47 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income | 47 |
| Preferred Stock And Other Adjustments | (1) |
|
| Net Income Applicable To Common Shares | $46 |
0.34% Nasdaq 0.00%
Income Statement
